Promising Results for Vertex’s Non-Opioid Pain Pill
Vertex Pharmaceuticals' experimental non-opioid pain pill, VX-548, has shown promising results in studies as a potential alternative to opioids...
VX-548
Vertex’s VX-548 Shows Promise as a Non-Opioid Pain Pill
In a mid-stage trial, Vertex Pharmaceuticals' new pain pill, VX-548, showed promising results in reducing pain for patients with...
Vertex Stock: Painkiller Could Drive Big Gains
Vertex Pharmaceuticals' stock could see a boost from its non-opioid painkiller, despite recent losses. The stock fell 9% after...
Vertex Shares Dip on Concerns Over Pain Pill Trial Design
Vertex Pharmaceuticals, a biotech company, saw its stock drop 9.5% this week after its chief operating officer revealed that...
Vertex Pharmaceuticals’ Potential Breakthrough in Nonaddictive Pain Relief
Americans filled one opioid pain prescription for every two U.S. adults in 2020, despite the ongoing opioid epidemic. Vertex...